The diagnostic approach to substance-induced aHUS should involve a thorough investigation of the patient’s drug use history along with ruling out STEC-HUS via stool tests, assessing ADAMTS13 activity to exclude TTP, and complement testing or genetic screening for aHUS. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.